Search results for "coronary occlusion"

showing 10 items of 59 documents

Protective effect of N-acetylcysteine on ischaemia-induced myocardial damage in canine heart.

1991

The glutathione redox pathway is an important antioxidant system in the myocardium. N-Acetylcysteine is a low molecular weight glutathione precursor that has been used clinically to replenish glutathione stores. The present study was aimed at evaluating the protective effect of N-acetylcysteine on myocardial damage resulting from permanent coronary occlusion (without reperfusion) in anaesthetized dogs. N-Acetylcysteine (150 mg kg−1 i.v.) administered 2 min before occlusion rerduced infarct size in dogs subjected to 24 h ischemia. The infarct size as a percentage of the area at risk was 86.8 ± 3.6% (n = 11) in control (salinetreated) dogs and 68.2 ± 2.4% (n = 7; P < 0.05 vs control) in N-ace…

Malemedicine.medical_specialtyMean arterial pressureTime FactorsIschemiaMyocardial InfarctionHemodynamicsCoronary DiseaseAcetylcysteinechemistry.chemical_compoundDogsInternal medicineCoronary CirculationmedicineAnimalsMyocardial infarctionPharmacologybusiness.industryGeneral MedicineGlutathionemedicine.diseaseMalondialdehydeGlutathioneAcetylcysteineDisease Models AnimalchemistryCoronary occlusionAnesthesiaCardiologyFemalebusinessmedicine.drugNaunyn-Schmiedeberg's archives of pharmacology
researchProduct

Increased plasma concentration of fibrin monomer in acute myocardial infarction with early reperfusion.

1996

OBJECTIVE To assess whether plasma fibrin monomer (FM) concentration, a marker of thrombin activity, is increased in the first hours after acute coronary occlusion and whether there are differences between patients with and without early reperfusion. DESIGN Thirty-five consecutive patients with acute myocardial infarction (AMI) and early coronary angiography were studied prospectively. METHODS Plasma FM samples taken on admission (< 6 h after onset of chest pain) and 6-14 h after onset of chest pain were analysed using a specific enzyme immunoassay. All of the patients were anticoagulated with heparin intravenously. RESULTS Of the 35 patients, 28 had angiographically documented reperfusion …

Malemedicine.medical_specialtyMyocardial InfarctionReference rangeMyocardial ReperfusionChest painCoronary AngiographySensitivity and SpecificityFibrin Fibrinogen Degradation ProductsImmunoenzyme TechniquesTroponin TInternal medicinemedicineHumansMyocardial infarctionProspective StudiesInfusions IntravenousCreatine KinasebiologyTroponin Tbusiness.industryHeparinAnticoagulantsGeneral MedicineHeparinMiddle Agedmedicine.diseaseFibrin MonomerTroponinCoronary occlusionbiology.proteinCardiologyCreatine kinaseFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessBiomarkersmedicine.drugCoronary artery disease
researchProduct

Impact of chronic total occlusion artery on 12-month mortality in patients with non-ST-segment elevation myocardial infarction treated by percutaneou…

2013

Abstract Background Three-vessel coronary artery disease is associated with high mortality in patients with non-ST-segment elevation myocardial infarction (NSTEMI). The purpose of this study was to assess the impact on 12‐month mortality of chronic total occlusion (CTO) in the non-infarct-related artery (non-IRA), as assessed by coronary angiography during percutaneous coronary intervention (PCI) for NSTEMI, of patients with 3-vessel disease. Methods The study included all of the NSTEMI patients with 3-vessel disease by coronary angiogram who were treated by PCI and who were registered in the prospective Polish Registry of Acute Coronary Syndromes (PL-ACS) from July 2007 to November 2009. T…

Malemedicine.medical_specialtyPercutaneous coronary interventions12-month mortalitymedicine.medical_treatmentMyocardial InfarctionCoronary artery diseasePercutaneous Coronary InterventionInternal medicinemedicineST segmentHumansMyocardial infarctionHospital MortalityProspective StudiesRegistriesAgedAged 80 and overNon‐ST-segment elevation myocardial infarctionbusiness.industryPercutaneous coronary interventionMiddle Agedmedicine.diseaseChronic total occlusionStenosismedicine.anatomical_structureTreatment OutcomeCoronary OcclusionConventional PCIInclusion and exclusion criteriaCardiologyFemaleCardiology and Cardiovascular MedicinebusinessArteryInternational journal of cardiology
researchProduct

Recanalization of complex coronary chronic total occlusions using high-frequency vibrational energy CROSSER catheter as first-line therapy: A single …

2010

Background: Several studies have illustrated the safety and the procedural outcome of high-frequency vibrational energy in guidewire refractory chronic total occlusions (CTOs). Aim: To evaluate the advantage of high-frequency vibrational energy device (CROSSER Catheter) use in coronary complex CTO revascularization as primary strategy. Methods: CROSSER was used as a primary approach if four or more unfavorable angiographic features were observed in the CTO lesions. Results: From May 2007 to February 2009, a CTO percutaneous intervention attempt was performed in 178 lesions of 171 patients (60.1 ± 8.9 age with 49.4 ± 7.2% in ejection fraction). Among these, the CROSSER was used in 46 complex…

Malemedicine.medical_specialtyPercutaneousTime Factorsmedicine.medical_treatmentPerforation (oil well)Contrast MediaRevascularizationVibrationCatheterizationMedicineHumansRadiology Nuclear Medicine and imagingMyocardial infarctionAngioplasty Balloon CoronaryAgedEjection fractionDose-Response Relationship Drugbusiness.industryPercutaneous coronary interventionEquipment DesignRecanalizationMiddle Agedmedicine.diseaseCROSSER.SurgeryCatheterCTOTreatment OutcomeCoronary OcclusionFluoroscopyChronic DiseaseFemaleCardiology and Cardiovascular MedicinebusinessMace
researchProduct

A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions

2018

Aims: The clinical value of percutaneous coronary intervention (PCI) for chronic coronary total occlusions (CTOs) is not established by randomized trials. This study should compare the benefit of PCI vs. optimal medical therapy (OMT) on the health status in patients with at least one CTO.Method and results: Three hundred and ninety-six patients were enrolled in a prospective randomized, multicentre, open-label, and controlled clinical trial to compare the treatment by PCI with OMT with a 2:1 randomization ratio. The primary endpoint was the change in health status assessed by the Seattle angina questionnaire (SAQ) between baseline and 12 months follow-up. Fifty-two percent of patients have …

Malemedicine.medical_specialtyRandomizationmedicine.medical_treatmentAdrenergic beta-AntagonistsAngiotensin-Converting Enzyme Inhibitors030204 cardiovascular system & hematologyAngina Pectorislaw.inventionAngina03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRandomized controlled triallawInternal medicinemedicineClinical endpointHumansPercutaneous transluminal interventioncardiovascular diseases030212 general & internal medicineMyocardial infarctionOptimal medical therapyAgedNitratesbusiness.industryAngina PectoriPercutaneous coronary interventionAngiotensin-Converting Enzyme InhibitorMiddle Agedmedicine.diseaseClinical trialCoronary OcclusionChronic coronary occlusion; EQ-5D; Optimal medical therapy; Percutaneous transluminal intervention; Seattle angina questionnaire; Cardiology and Cardiovascular MedicineConventional PCIChronic DiseaseChronic coronary occlusionQuality of LifeSeattle angina questionnaireFemaleHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitors
researchProduct

Apoptosis is not involved in the mechanism of myocardial dysfunction after resuscitation in a rat model of cardiac arrest and cardiopulmonary resusci…

2010

OBJECTIVE To investigate the presence of apoptosis after the global myocardial ischemia of cardiopulmonary resuscitation and the regional myocardial ischemia after left anterior descending coronary artery occlusion and relate it to the severity of postresuscitation myocardial dysfunction. DESIGN Prospective animal study. SETTING University-affiliated animal research laboratory. SUBJECTS Male Sprague-Dawley rats. INTERVENTIONS Fifteen male Sprague-Dawley rats weighing 450-550 g were randomized to: (1) 8 mins of untreated cardiac arrest followed by 6 mins of cardiopulmonary resuscitation; (2)left anterior descending coronary artery occlusion for 45 mins followed by 4 hrs of reperfusion; and (…

Malemedicine.medical_specialtyResuscitationmedicine.medical_treatmentIschemiaMyocardial IschemiaApoptosisMyocardial Reperfusion Injurycardiac arrestischemiaAnterior Descending Coronary ArteryCritical Care and Intensive Care MedicineRats Sprague-DawleyRandom AllocationInternal medicineOcclusionmedicineAnimalsCardiopulmonary resuscitationEjection fractionbusiness.industryHeartmedicine.diseaseapoptosiCardiopulmonary ResuscitationreperfusionHeart ArrestRatsCoronary OcclusionVentricular pressureCardiologybusinessClinical deathCritical care medicine
researchProduct

Feasibility of Implanting 50-60 mm-Tapered Drug Eluting Stents in Chronic Total Occlusions.

2018

Abstract Background Percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) usually involves multiple overlapping stents implantation to cover long coronary segments. A higher rate of restenosis has been described with stent overlapping. Recently, new long tapered stents emerged as a potential tool for treating long coronary lesions. Feasibility of using these new devices for the CTO PCI has not been described. The aim of this work was to describe our initial experience with 50 and 60 mm-long tapered sirolimus-eluting stents (SES) in CTO PCI. Methods We included 54 consecutive patients who underwent a CTO PCI and in whom an attempt to implant a 50 or 60 mm-long tapered SE…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentTarget vessel030204 cardiovascular system & hematologyProsthesis DesignCoronary Restenosis03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRestenosismedicineHumanscardiovascular diseases030212 general & internal medicineVascular PatencyAgedRetrospective StudiesSirolimusbusiness.industryPercutaneous coronary interventionStentCardiovascular AgentsDrug-Eluting StentsGeneral MedicineMiddle Agedmedicine.diseaseSurgerysurgical procedures operativeTreatment OutcomeCoronary OcclusionConventional PCIChronic DiseaseFeasibility StudiesFemaleImplantCardiology and Cardiovascular MedicinebusinessCardiovascular revascularization medicine : including molecular interventions
researchProduct

Percutaneous coronary intervention of chronic total occlusions in patients with low left ventricular ejection fraction

2017

Abstract Objectives The study sought to assess the outcome of percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) in patients with low left ventricular ejection fraction (LVEF) (≤35%). Background Data regarding the outcome of PCI in patients with low LVEF affected by CTO are scarcely reported. Methods The authors performed a prospective longitudinal multicenter study including consecutive patients undergoing elective PCI of CTOs. Patients were subdivided into 3 groups: group 1 (LVEF ≥50%), group 2 (LVEF 35% to 50%), and group 3 (LVEF ≤35%). Results A total of 839 patients (mean 64.6 ± 10.5 years of age, 87.7% men) underwent CTO PCI attempts. Baseline LVEF ≤35% was pr…

Malemedicine.medical_specialtyanimal structuresTime Factorsmedicine.medical_treatment610 Medicine & healthKaplan-Meier Estimate030204 cardiovascular system & hematologyCoronary AngiographyDisease-Free SurvivalVentricular Function Left2705 Cardiology and Cardiovascular Medicinechronic total occlusion; ischemic LV dysfunction; left ventricular ejection fraction; PCI; Cardiology and Cardiovascular Medicinechronic total occlusionischemic LV dysfunctionleft ventricular ejection fractionPCI03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionRisk FactorsInternal medicinemedicineHumansIn patientcardiovascular diseases030212 general & internal medicineLongitudinal StudiesProspective Studieschronic total occlusionAgedProportional Hazards ModelsEjection fractionbusiness.industryPercutaneous coronary interventionleft ventricular ejection fractionPCIStroke VolumeRecovery of FunctionMiddle AgedSurgeryEuropeTreatment OutcomeCoronary OcclusionConventional PCIChronic DiseaseCardiology10209 Clinic for CardiologyFemalebusinessCardiology and Cardiovascular Medicineischemic LV dysfunction
researchProduct

European experience with the retrograde approach for the recanalization of coronary artery chronic total occlusions. A report on behalf of the EuroCT…

2008

Aims Recanalisation rates of coronary chronic total occlusions (CTO) remain sub-optimal. The retrograde technique was recently introduced to improve success rates. Methods and results From February 2005 until December 2007, 175 patients were treated with this technique in seven European centres by highly experienced operators: in 84 (48%) as primary strategy, in 41 (23.5%) immediately after antegrade failure and in 50 (28.5%) as a repeat procedure after previous antegrade failure. Baseline characteristics revealed a mean age 61.4 +/- 10.8 years with 29.5% and 39% of patients having diabetes and a prior history of MI, respectively. The mean occlusion duration was 50.8 months (determined in 3…

Malemedicine.medical_specialtymedicine.medical_treatmentCollateral CirculationCoronary AngiographyBalloonCoronary circulationCoronary CirculationAngioplastyOcclusionmedicineHumansMyocardial infarctionAngioplasty Balloon CoronarySeptal collaterals.Agedbusiness.industryMiddle Agedmedicine.diseaseCollateral circulationSurgeryEuropeChronic total occlusionTreatment Outcomemedicine.anatomical_structureCoronary OcclusionCoronary occlusionChronic DiseaseRetrogradeFemaleCardiology and Cardiovascular MedicinebusinessArtery
researchProduct

Management strategies in patients affected by chronic total occlusions: results from the Italian Registry of Chronic Total Occlusions

2015

Background Through contemporary literature, the optimal strategy to manage coronary chronic total occlusions (CTOs) remains under debate. Objectives The aim of the Italian Registry of Chronic Total Occlusions (IRCTO) was to provide data on prevalence, characteristics, and outcome of CTO patients according to the management strategy. Methods The IRCTO is a prospective real world multicentre registry enrolling patients showing at least one CTO. Clinical and angiographic data were collected independently from the therapeutic strategy [optimal medical therapy (MT), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG)]; a comparative 1-year clinical followup was pe…

Malemedicine.medical_specialtymedicine.medical_treatmentLeftCoronary AngiographyVentricular Dysfunction LeftCoronary artery bypass surgeryPercutaneous Coronary InterventionInternal medicineVentricular DysfunctionPrevalenceHumansMedicineProspective StudiesRegistriesMyocardial infarctionCoronary Artery BypassProspective cohort studyCABGAgedbusiness.industryChronic total occlusion † Registry † PCI † CABG † Optimal medical therapyPercutaneous coronary interventionCardiovascular AgentsPCImedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareChronic total occlusionTreatment Outcomemedicine.anatomical_structureCoronary OcclusionItalyCoronary occlusionChronic total occlusion; PCI; CABGChronic DiseaseCardiovascular agentConventional PCICardiologyFemaleCardiology and Cardiovascular MedicinebusinessArteryEuropean Heart Journal
researchProduct